Prospective Open Label Study of Solifenacin for Overactive Bladder in Children
Author:
Affiliation:
1. Division of Urology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Québec, Canada
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference27 articles.
1. Muscarinic receptor antagonists for overactive bladder;Abrams;BJU Int,2007
2. Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder;Chapple;BJU Int,2004
3. Preliminary study of the safety and efficacy of extended-release oxybutynin in children;Youdim;Urology,2002
4. The use of tolterodine in children after oxybutynin failure;Bolduc;BJU Int,2003
5. Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children;Ayan;BJU Int,2005
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Enuresis und nicht-organische (funktionelle) Harninkontinenz bei Kindern und Jugendlichen – klinische Leitlinie zur Diagnostik und Therapie;Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie;2023-09
2. Neurogenic Lower Urinary Tract Dysfunction;Urologic Clinics of North America;2023-08
3. Updates of Overactive Bladder in Pediatrics;International Neurourology Journal;2023-03-31
4. Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review;Journal of Pediatric Urology;2023-02
5. Voiding Disorders in Children;Pediatric Kidney Disease;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3